Douglas J. Williamson

Insider Reports History

Location
Dublin, Ireland
Signature
/s/ Austin D. Kim, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas J. Williamson:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC Executive VP, Research & Dev Restricted Stock Units 50,655 $1,517,624 $29.96 10 Feb 2023 Direct
AVADEL PHARMACEUTICALS PLC Chief Medical Officer Stock Option (Right to Buy) 275,000 14 Feb 2022 Direct
ACADIA PHARMACEUTICALS INC Executive VP, Research & Dev Non-Qualified Stock Option (Right to Buy) 237,296 10 Feb 2023 Direct

Insider Reports Filed by Douglas J. Williamson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACAD ACADIA PHARMACEUTICALS INC 10 Feb 2023 2 $0 4 Executive VP, Research & Dev 13 Feb 2023, 17:45
ACAD ACADIA PHARMACEUTICALS INC 01 Feb 2023 0 $0 3 Executive VP, Research & Dev 13 Feb 2023, 17:40
AVDL AVADEL PHARMACEUTICALS PLC 14 Feb 2022 1 $0 4 Chief Medical Officer 16 Feb 2022, 15:40
AVDL AVADEL PHARMACEUTICALS PLC 14 Feb 2022 0 $0 3 Chief Medical Officer 16 Feb 2022, 15:25